While we have only done limited testing for events diabetics, we believe Auxulin should reduce the magnitude and duration of events hyperglycemic events, especially for those events who use insulin
Frequently Ask Question
Though we didn’t run a robust clinical trial testing Auxulin’s impact on A1C percentages, we measured the hemoglobin A1C levels for Tommy and Gary (Auxulin's founders) who consistently took the product over a period of several months. Over a 4-to-6-month period, they experienced an average A1C percentage reduction of nearly 0.1 percent per month. Tommy and Gary's A1C percentages have remained at lifelong lows.
Auxulin was founded by Dr. Gary Ritz and his son, Tommy Ritz. Gary has been living with T1D since 1984, and Tommy has been a T1D since 1998. Tired of their daily battles to manage their diabetes, which often resulted in prolonged periods of high blood sugar. The father/son duo sought a better way to combat hyperglycemia, which eventually led to the development of Auxulin. Auxulin is a supplement that, when used in conjunction with insulin and water, returned their high blood sugar levels to normal in a much faster time frame. They had several of their Type 1 friends and family members try it, and found it worked for them as well. Auxulin is an all-natural formulation. All of its active ingredients are widely available in food products and routinely ingested in some form by most people. Both Gary and Tommy used Auxulin regularly to help manage their diabetes, and want to bring Auxulin to the rest of the diabetic world.
Auxulin founders, working in conjunction with Dr. Jason McDevitt at the College of William & Mary, developed a formulation that safely and economically works in conjunction with insulin to reduce the duration and magnitude of hyperglycemic events. This patented technology was licensed from William & Mary to the company.